Ionis Pharmaceuticals, Inc.
IONS
Classement en actions
#2545
Founded in 1989 and headquartered in Carlsbad, California, Ionis... Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc. Additionally, it holds licensing and collaboration agreements with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc.
Prix de l'action
$44.62
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$7.41B
Changement (1 jour)
-1.73%
Changement (1 an)
-37.60%
Pays
US
Échange Ionis Pharmaceuticals, Inc. (IONS)
Catégorie
Healthcare
Historique du prix de l'action pour Ionis Pharmaceuticals, Inc. (IONS)
Prix de clôture le plus élevé : $43.87 le 2026-10-01
Prix de clôture le plus bas : $9.35 le 1991-05-01
Prix de clôture le plus bas : $9.35 le 1991-05-01
Historique du prix de l'action de Ionis Pharmaceuticals, Inc. de 1991 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -12.44% |
| 2025 | 118.12% |
| 2024 | -26.68% |
| 2023 | 30.56% |
| 2022 | 26.76% |
| 2021 | -42.71% |
| 2020 | -15.83% |
| 2019 | 18.26% |
| 2018 | 1.41% |
| 2017 | 8.18% |
| 2016 | -17.46% |
| 2015 | 0.07% |
| 2014 | 49.87% |
| 2013 | 299.73% |
| 2012 | 39.38% |
| 2011 | -29.73% |
| 2010 | -5.16% |
| 2009 | -14.30% |
| 2008 | -25.93% |
| 2007 | 41.58% |
| 2006 | 123.48% |
| 2005 | -11.84% |
| 2004 | 1.13% |
| 2003 | -15.98% |
| 2002 | -68.29% |
| 2001 | 125.06% |
| 2000 | -2.89% |
| 1999 | -13.03% |
| 1998 | -10.89% |
| 1997 | -28.15% |
| 1996 | 42.62% |
| 1995 | 203.93% |
| 1994 | -36.55% |
| 1993 | -34.00% |
| 1992 | -20.56% |
| 1991 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $766.95 | 9.01% |
CH
|
